with streak ovaries without graafian follicles and also with shortness of stature and a variety of associated congenital malformations such as a shield-like chest with widely spaced nipples, lymphoedema of the legs in infancy, hypoplastic nails, pigmented nmvi, coarctation of the aorta, abnormal angle of the carpal bones and a short fourth metacarpal bone. Not all these features may be present in a given case. The commonest chromosomal abnormality is monosomy of the X-chromosome but many other chromosomal abnormalities have been described (Ferguson-Smith 1965) .
The anatomical and clinical features of a patient with Turner's syndrome are largely determined by the precise abnormality in the chromosomal composition. Those with 'classical' features of Turner's syndrome have in conunon a deficiency of the short arm of an X-chromosome; the commonest abnormality is an XO constitution but less commonly there is an isochromosome of the long arm of an X-chromosome or just deletion of the short arm. In contrast the sole abnormalities found in those with an absence of the long arm of an X-chromosome are primary amenorrhoea and streak ovaries without the other stigmata of Turner's syndrome. Features of masculinization with clitoral hypertrophy and some testicular differentiation of the gonads may occur when the chromosomal pattern is XO/XY, XS (probable small abnormal Y-chromosome), XO/XS, XO A patient aged 33 with secondary amenorrhcea and infertility was excreting consistently large quantities of urinary gonadotrophin. She responded to treatment with exogenous gonadotrophins and conceived.
TIwo similar patients were also described and an analysis given of45 other patients who had had urinary gonadotrophins measured on at least three "Wellcome Trust Research Fellow occasions before starting treatment. Seventeen of the latter had excreted more than 50 mg 1st IRP-HMG/24 h at one time or another. The other 28 had excreted consistently smaller quantities. No significant differences were found between these two groups of patients in the proportion responding to treatment in the dosages of FSH required for inducing ovulation, in the incidence of pregnancies occurring in each group or in the dosages of FSH given in the months in which the patients conceived. Gonadotrophin analysis results used by other authors for selecting patients for treatment were reviewed, and the need to make at least three estimations was emphasized.
Pituitary Apoplexy R J Cryer MB MRCP (for D Ferriman DM FRCP) (North Middlesex Hospital, Edmonton, London N18) Mr J T, aged 56 History: Admitted to Kingston Hospital on 14.5.60 with sudden onset of severe headache and vomiting, pyrexia, photophobia and meningism with right facial weakness and a right extensor plantar. Cerebrospinal fluid was initially normal but later yielded polymorphs and increased protein, followed by lymphocytes. Since this illness he has been tired, weak, apathetic and impotent. He felt the cold excessively, and lost weight. He complained of nocturia and left frontal headaches.
On examination (April 1969): Wasted and depressed, with sparse body hair and little beard growth, pallid inelastic skin. Blood pressure 120/80. Investigations: No hrmatological or electrolyte abnormality. Four-hour 133I uptake 16%, proteinbound iodine 3-8 pg/100 ml, T3 resin uptake 29 % (normal 25-35 %). Plasma 'cortisol' 50 pg/100 ml, with no response to the stress of pyrogen.
Urinary 17-oxosteroid excretion 3 5, oxogenic steroids 2 5 mg/24 h. There was no response to metyrapone, but oxogenic steroids rose slowly on adrenocorticotrophic hormone stimulation to 4-8 mg on Day 1, 15-0 mg on Day 2, and 16-8 mg on Day 3. Chest X-ray showed no abnormality; views of the pituitary fossa, including tomograms, showed equivocal enlargement. A diagnosis of hypopituitarism was made on these results. Treatment: He was started on cortisone, and later thyroxine replacement therapy, with prompt improvement in well-being, weight gain, and rise in blood pressure to 140/90.
Comment
He probably infarcted his pituitary or a tumour in it during the original illness; more recent X-rays show definite evidence of enlargement of the pituitary fossa. (Rakieten et al. 1963) with antitumour activity (Evans et al. 1965) . Treatment with streptozotocin: October 1968: An initial course of three intravenous infusions of streptozotocin (2 g, 2 g, 4 g; 2-hour infusion time) was ineffective. December 1968: A second course of three infusions (1 g, 2 g, 1-5 g; 10-min infusion time) given through an indwelling catheter into the coeliac axis increased blood glucose and reduced plasma insulin levels, but diazoxide therapy was still necessary. March 1969: A third course of seven infusions (2-5 g each; 10-min infusion time) given into the coeliac axis gave dramatic improvement and allowed us to discontinue diazoxide. For seven months he was normoglycmmic, but then he deteriorated and diazoxide was reintroduced. March 1970: A fourth course of four intravenous infusions (2 g, 2 g, 2 g, 4 g; 10-min infusion time) restored normal blood glucose levels but diazoxide could not be withdrawn.
Coeliac axis arteriography before and after each intra-arterial course of streptozotocin showed progressive reduction in the vascularity of hepatic metastases. Mild hepatic and renal injury were temporary side-effects after the third and fourth courses of treatment.
Response to streptozotocin may depend on peak tissue levels. Rapid infusion and local administration into the cceliac axis were most effective. The cceliac axis route could minimize its renal toxicity, provided that care is taken to avoid spill over into the renal arteries.
A fuller account of this case has already been published (Stanley et al. 1970 ).
